Head-to-head Study of Erenumab Against Topiramate in Patients With Episodic and Chronic Migraine
Clinical trial NCT03828539 · COMPLETED
Trial details
- NCT number
- NCT03828539
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-22
- Primary completion
- 2020-07-29
- Enrollment
- 777
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.